Beladev Shavit 4

What Happened Beladev Shavit, VP Plasma Operations at Kamada Ltd. (KMDA), was reported as receiving five award/derivative acquisitions of 15,000 shares each (total 75,000) on April 7, 2026, and on the same date had five corresponding dispositions to the issuer of 15,000 shares each (total 75,000). All transactions are reported as derivative transactions (codes A = grant/award/acquisition, D = disposition to the issuer); exercise prices and dollar values are listed as N/A in the filing.

Key Details

• Transaction date: April 7, 2026; Form 4 filed April 9, 2026 (timely filing).
• Reported entries: five grants (15,000 each) and five dispositions to issuer (15,000 each) — total acquired 75,000 and total disposed 75,000.
• Price/value: listed as N/A (derivative awards; exercise price shown as N/A in the transaction lines). Footnote notes USD conversions are convenience from NIS (F1).
• Shares owned after transaction: not specified in the transaction lines of this summary Form 4.
• Relevant footnotes from the filing:
  • F2: Exercise price of the options was adjusted per the 2011 Share Award Plan following a cash dividend declared Mar 11, 2026.
  • F3: Options vest in four equal annual installments (25% per year).
  • F4: Awards are held by a trustee under the Company’s 2011 Share Award Plan.
• No late filing flag noted in the Form 4.

Context

• These are derivative award transactions under the company’s share award plan. The paired grant and disposition to the issuer on the same date often reflect plan mechanics (e.g., settlement, withholding or transfer back to the company) rather than an open-market sale or purchase.
• For retail investors: grant awards are not the same as a market buy (which is typically a stronger bullish signal). The filing is mainly reporting compensation-related equity activity rather than a directional trade.